These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
298 related articles for article (PubMed ID: 7607048)
1. Effect of a potent new aldose reductase inhibitor, (5-(3-thienyltetrazol-1-yl)acetic acid (TAT), on diabetic neuropathy in rats. Hotta N; Kakuta H; Fukasawa H; Koh N; Sakakibara F; Nakamura J; Hamada Y; Wakao T; Hara T; Mori K Diabetes Res Clin Pract; 1995 Feb; 27(2):107-17. PubMed ID: 7607048 [TBL] [Abstract][Full Text] [Related]
2. Effects of a new aldose reductase inhibitor, (2S, 4S)-6-fluoro-2',5'-dioxospiro[chroman-4,4'-imidazolidine]-2-ca rboxamid e (SNK-860), on the slowing of motor nerve conduction velocity and metabolic abnormalities in the peripheral nerve in acute streptozotocin-induced diabetic rats. Mizuno K; Kato N; Matsubara A; Nakano K; Kurono M Metabolism; 1992 Oct; 41(10):1081-6. PubMed ID: 1328819 [TBL] [Abstract][Full Text] [Related]
4. Prevention of defects of axonal transport and nerve conduction velocity by oral administration of myo-inositol or an aldose reductase inhibitor in streptozotocin-diabetic rats. Mayer JH; Tomlinson DR Diabetologia; 1983 Nov; 25(5):433-8. PubMed ID: 6197336 [TBL] [Abstract][Full Text] [Related]
5. Diabetic neuropathy in sucrose-fed Otsuka Long-Evans Tokushima fatty rats: effect of an aldose reductase inhibitor, TAT. Nakamura J; Koh N; Sakakibara F; Hamada Y; Wakao T; Sasaki H; Mori K; Nakashima E; Naruse K; Hotta N Life Sci; 1997; 60(21):1847-57. PubMed ID: 9154994 [TBL] [Abstract][Full Text] [Related]
6. Characterization of a novel aldose reductase inhibitor, TAT, and its effects on streptozotocin-induced diabetic neuropathy in rats. Inukai S; Agata M; Sato M; Naitou A; Matsukawa H; Goto M Jpn J Pharmacol; 1993 Mar; 61(3):221-7. PubMed ID: 8483299 [TBL] [Abstract][Full Text] [Related]
7. Comparison of the effects of inhibitors of aldose reductase and sorbitol dehydrogenase on neurovascular function, nerve conduction and tissue polyol pathway metabolites in streptozotocin-diabetic rats. Cameron NE; Cotter MA; Basso M; Hohman TC Diabetologia; 1997 Mar; 40(3):271-81. PubMed ID: 9084964 [TBL] [Abstract][Full Text] [Related]
8. The role of cyclic adenosine 3',5'-monophosphate and polyol metabolism in diabetic neuropathy. Shindo H; Tawata M; Aida K; Onaya T J Clin Endocrinol Metab; 1992 Feb; 74(2):393-8. PubMed ID: 1370506 [TBL] [Abstract][Full Text] [Related]
9. Physiological and morphometric analyses of neuropathy in sucrose-fed OLETF rats. Nakamura J; Hamada Y; Sakakibara F; Hara T; Wakao T; Mori K; Nakashima E; Naruse K; Kamijo M; Koh N; Hotta N Diabetes Res Clin Pract; 2001 Jan; 51(1):9-20. PubMed ID: 11137177 [TBL] [Abstract][Full Text] [Related]
10. Myo-inositol and sorbitol metabolism in relation to peripheral nerve function in experimental diabetes in the rat: the effect of aldose reductase inhibition. Gillon KR; Hawthorne JN; Tomlinson DR Diabetologia; 1983 Oct; 25(4):365-71. PubMed ID: 6416913 [TBL] [Abstract][Full Text] [Related]
11. Aldose reductase inhibition, nerve perfusion, oxygenation and function in streptozotocin-diabetic rats: dose-response considerations and independence from a myo-inositol mechanism. Cameron NE; Cotter MA; Dines KC; Maxfield EK; Carey F; Mirrlees DJ Diabetologia; 1994 Jul; 37(7):651-63. PubMed ID: 7958535 [TBL] [Abstract][Full Text] [Related]
12. Effect of propionyl-L-carnitine on motor nerve conduction, autonomic cardiac function, and nerve blood flow in rats with streptozotocin-induced diabetes: comparison with an aldose reductase inhibitor. Hotta N; Koh N; Sakakibara F; Nakamura J; Hamada Y; Wakao T; Hara T; Mori K; Naruse K; Nakashima E; Sakamoto N J Pharmacol Exp Ther; 1996 Jan; 276(1):49-55. PubMed ID: 8558455 [TBL] [Abstract][Full Text] [Related]
13. Polyol pathway hyperactivity is closely related to carnitine deficiency in the pathogenesis of diabetic neuropathy of streptozotocin-diabetic rats. Nakamura J; Koh N; Sakakibara F; Hamada Y; Hara T; Sasaki H; Chaya S; Komori T; Nakashima E; Naruse K; Kato K; Takeuchi N; Kasuya Y; Hotta N J Pharmacol Exp Ther; 1998 Dec; 287(3):897-902. PubMed ID: 9864270 [TBL] [Abstract][Full Text] [Related]
14. Osmotically-induced nerve taurine depletion and the compatible osmolyte hypothesis in experimental diabetic neuropathy in the rat. Stevens MJ; Lattimer SA; Kamijo M; Van Huysen C; Sima AA; Greene DA Diabetologia; 1993 Jul; 36(7):608-14. PubMed ID: 8359577 [TBL] [Abstract][Full Text] [Related]
15. Interactions between essential fatty acid, prostanoid, polyol pathway and nitric oxide mechanisms in the neurovascular deficit of diabetic rats. Cameron NE; Cotter MA; Hohman TC Diabetologia; 1996 Feb; 39(2):172-82. PubMed ID: 8635669 [TBL] [Abstract][Full Text] [Related]